Home/Filings/4/0000950170-24-080961
4//SEC Filing

Michaelson Jennifer 4

Accession 0000950170-24-080961

CIK 0001789972other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 7:30 PM ET

Size

5.4 KB

Accession

0000950170-24-080961

Insider Transaction Report

Form 4
Period: 2024-07-01
Michaelson Jennifer
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2024-07-01$9.00/sh+2,360$21,240131,942 total
Footnotes (2)
  • [F1]The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2021 Employee Stock Purchase Plan (the "ESPP"), for the purchase period of January 1, 2024 through June 30, 2024. This transaction is also exempt under Rule 16b-3(c).
  • [F2]In accordance with the ESPP, the shares were purchased based on 85% of the closing price of the Issuer's common stock on January 2, 2024.

Documents

1 file

Issuer

Cullinan Therapeutics, Inc.

CIK 0001789972

Entity typeother

Related Parties

1
  • filerCIK 0001838061

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 7:30 PM ET
Size
5.4 KB